Here's the Deal
 

Baird's Investment Banking Group is pleased to announce the following transaction:

June 2012


Affymetrix, Inc.
Convertible Senior Notes
$105.0 Million


Baird served as a co-manager in this offering


Affymetrix, Inc. (“Affymetrix” or the “Company”) (NasdaqGS: AFFX) recently priced an offering of $105 million aggregate principal amount of unsecured 4.00% Convertible Senior Notes due 2019. The Company intends to use the net proceeds from the offering to fund a portion of the purchase price for its acquisition of eBioscience Holding Company, Inc.

Affymetrix technology is used by the world's top pharmaceutical, diagnostic and biotechnology companies, as well as leading academic, government and nonprofit research institutes. More than 2,200 systems have been shipped around the world and almost 25,000 peer-reviewed papers have been published using the technology. Affymetrix is headquartered in Santa Clara, California and has manufacturing facilities in Cleveland, Ohio and Singapore. The Company has about 900 employees worldwide and maintains sales and distribution operations across Europe, Asia and Latin America.

For additional information about this transaction, please contact:
Co-Head, Equity Capital Markets
(415) 627-3279
Director
(650) 858-3817
Vice President
(414) 765-3802

Social Icons

Careers|Help|Site Map|Important Disclosures|Privacy Policy|Financial Information|Business Continuity
©2013 Robert W. Baird & Co. Incorporated.
Global Websites: Europe | Asia
The services featured on this Web site may not be available in all jurisdictions or to all persons/entities. For more information, please see Important Disclosures. Robert W. Baird & Co. Incorporated. Member SIPC.